Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Nogenol
2. Lassar Paste
3. Lassar's Paste
4. Lassars Paste
5. Oxide, Zinc
6. Paste, Lassar's
1. Oxozinc
2. Zinc White
3. Zinc Oxide Powder
4. Amalox
5. Chinese White
6. Snow White
7. Emanay Zinc Oxide
8. Felling Zinc Oxide
9. Akro-zinc Bar 85
10. Flowers Of Zinc
11. Mfcd00011300
12. Azo-33
13. Outmine
14. Supertah
15. Zincite
16. Zincoid
17. Azodox
18. Ozide
19. Ozlo
20. Zinc Monoxide
21. Lassars Paste
22. Flores De Zinci
23. Lassar Paste
24. Zinci Oxicum
25. Hubbuck's White
26. Blanc De Zinc
27. Unichem Zo
28. Vandem Vac
29. Vandem Voc
30. Vandem Vpc
31. Green Seal-8
32. Philosopher's Wool
33. White Seal-7
34. K-zinc
35. Zno
36. Powder Base 900
37. Protox Type 166
38. Protox Type 167
39. Protox Type 168
40. Protox Type 169
41. Protox Type 267
42. Protox Type 268
43. Akro-zinc Bar 90
44. Azodox-55
45. Azodox-55tt
46. Red Seal 9
47. Emar
48. Ci Pigment White 4
49. Electrox 2500
50. Actox 14
51. Actox 16
52. Kadox 15
53. Kadox 72
54. Kadox-25
55. Zinc Oxide [usan]
56. Zinca 20
57. Protox 166
58. Protox 168
59. Protox 169
60. Caswell No. 920
61. Electox 2500
62. Cadox Xx 78
63. Actox 216
64. Cynku Tlenek [polish]
65. Desitin
66. Nogenol
67. C-weiss 8 [german]
68. Zincum Oxidatum
69. Azo-55tt
70. Azo-66tt
71. Azo-77tt
72. Cynku Tlenek
73. Zinc Gelatin
74. Oxyde De Zinc
75. Zinc Oxide Fume
76. Rvpaque
77. Azo 22
78. Azo-55
79. Azo-66
80. Azo-77
81. No-genol
82. Zinc Oxide Substrate, 10x10x0.5mm, Polished One Side, 0001 Orientation
83. Zinc Oxide Substrate, 10x10x0.5mm, Polished Two Sides, 0001 Orientation
84. Pigment White 4
85. Zinc Oxide, 99.99% Trace Metals Basis
86. 174846-84-5
87. Giap 10
88. Ccris 1309
89. C-weiss 8
90. Zn 0701t
91. Hsdb 5024
92. A&d Medicated Ointment
93. Xx 78
94. Einecs 215-222-5
95. Unii-soi2loh54z
96. Zinc Oxide [usp:jan]
97. Xx 203
98. Xx 601
99. Epa Pesticide Chemical Code 088502
100. Zinkoxid
101. Ai3-00277
102. Oxido De Cinc
103. Leaded Zinc Oxide
104. Zn-0401 E 3/16''
105. Zno Quantum Dots
106. Zinc Oxide Slurry
107. Zinc Oxide, Heavy
108. Zinc Oxide (tn)
109. Zinc Oxide Nanowire
110. Zinc Oxide Nanowires
111. Zine Oxide ,(s)
112. Zinc Oxide Dispersion
113. Zinc Oxide Nanopowder
114. Zinc Oxide, Nanotek?
115. Zinc Oxide Nanoparticle
116. Zinc Oxide, Puratronic
117. Zinc Oxide Quantum Dots
118. Zinc Oxide,99.99%
119. Ec 215-222-5
120. Zinc Oxide (jp17/usp)
121. Zinc Oxide, Sintered Tablets
122. Zinc Oxide, Lr, >=99%
123. Aluminium Doped Zno Dispersion
124. Zinc Oxide [usan:usp:jan]
125. Zinc Oxide, Analytical Standard
126. Zinc Oxide Nanopowder Dispersion
127. Chebi:36560
128. Zinc Oxide Nanopowder (type I)
129. Zinc Oxide, Nanoarc Zn-0605
130. Zinc Oxide, P.a., 99.0%
131. Zinc Oxide Nanopowder (type Ii)
132. Zinc Oxide Dispersion Wood Coating
133. Zinc Oxide Powder, 99.9% Nano
134. Yttrium Doped Zinc Oxide Dispersion
135. Europium Doped Zinc Oxide Dispersion
136. Zinc Oxide, Usp, 99-100.5%
137. Akos015904168
138. Zinc Oxide Nanoparticles / Nanopowder
139. Db09321
140. Zinc Oxide, Acs Reagent, >=99.0%
141. Zinc Oxide, 99.999% (metals Basis)
142. Zinc Oxide, 30nm,20 Wt.% Isopropanol
143. Zinc Oxide, Tested According To Ph.eur.
144. 8051-03-4
145. Zinc Oxide, 99.999% Trace Metals Basis
146. Zinc Oxide, Saj First Grade, >=99.0%
147. Zinc Oxide, Jis Special Grade, >=99.0%
148. Cs-0179846
149. Ft-0631786
150. Ft-0640838
151. Ft-0645092
152. Antimony Tin Dioxide (ato) Sputtering Targets
153. D01170
154. Zinc Oxide, Nanopowder, <100 Nm Particle Size
155. Q190077
156. Zinc Oxide Nanodispersion Type A-nonionic (70nm)
157. Zinc Oxide Nanodispersion Type B-anionic (70nm)
158. Zinc Oxide Nanodispersion Type C-cationic (70nm)
159. Zinc Oxide, Nanowires, Diam. X L 90 Nm X 1 Mum
160. J-005999
161. Zinc Oxide, Nanowires, Diam. X L 50 Nm X 300 Nm
162. Zinc Oxide, Nanowires, Diam. X L 300 Nm X 4-5 Mum
163. Zinc Oxide, Puriss. P.a., Acs Reagent, >=99.0% (kt)
164. Azo Powder / Azo Micropowder / Zno Doped With Metal Aluminum
165. Zinc Oxide, Nanopowder, <50 Nm Particle Size (bet), >97%
166. Zinc Oxide, Reagentplus(r), Powder, <5 Mum Particle Size, 99.9%
167. Zinc Oxide, United States Pharmacopeia (usp) Reference Standard
168. 20 Wt% Zinc Oxide In Water, 20 Wt% (zno) (pale Yellow Powder), >99% Nano
169. Zinc Oxide Sputtering Target, 50.8mm (2.0in) Dia X 3.18mm (0.125in) Thick
170. Zinc Oxide Sputtering Target, 50.8mm (2.0in) Dia X 6.35mm (0.250in) Thick
171. Zinc Oxide Sputtering Target, 76.2mm (3.0in) Dia X 6.35mm (0.250in) Thick
172. Zinc Oxide, Dispersion, Nanoparticles, <110 Nm Particle Size, 40 Wt. % In Butyl Acetate
173. Zinc Oxide, Dispersion, Nanoparticles, 40 Wt. % In Ethanol, <130 Nm Particle Size
174. Zinc Oxide, Dispersion, Nanoparticles, <100 Nm Particle Size (tem), <=40 Nm Avg. Part. Size (aps), 20 Wt. % In H2o
175. Zinc Oxide, Nanotek Z1102pma, 50% In 1,2-propanediol Monomethyl Ether Acetate, Colloidal Dispersion
176. Zinc Oxide, Puriss., Meets Analytical Specification Of Ph. Eur., Bp, Usp, 99-100.5% (calc. For Dried Substance)
177. Zinc Oxide, Sputtering Target, Diam. X Thickness 3.00 In. X 0.125 In., 99.99% Trace Metals Basis
Molecular Weight | 81.4 g/mol |
---|---|
Molecular Formula | OZn |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Exact Mass | 79.924056 g/mol |
Monoisotopic Mass | 79.924056 g/mol |
Topological Polar Surface Area | 17.1 Ų |
Heavy Atom Count | 2 |
Formal Charge | 0 |
Complexity | 2 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For adjunctive treatment of diaper dermatitis. Also, it can be used to treat minor skin irritations (eg, cuts, burns, and scrapes, poison ivy). Zinc oxide can be used in ointments, creams, and lotions to protect against sunburn and other damage to the skin caused by ultraviolet light.
FDA Label
Zinc oxide has astringent, soothing and protective properties and is used in topical preparations for eczema, slight excoriations, wounds and haemorrhoids. It also reflects ultraviolet radiation and can be used as a physical sunscreen.
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)
Sunscreening Agents
Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)
Absorption
No significant percutaneous absorption from topically applied zinc oxide.
Route of Elimination
Intended for local use only, no systemic absorption.
Volume of Distribution
Intended for local use only, no systemic absorption.
Clearance
Intended for local use only, no systemic absorption.
Intended for local use only, no systemic absorption.
Intended for local use only, no systemic absorption.
It acts by providing a physical barrier to prevent skin irritation and help heal damaged skin.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34040
Submission : 2019-09-16
Status : Active
Type : II
Certificate Number : CEP 2018-254 - Rev 02
Issue Date : 2025-01-29
Type : Chemical
Substance Number : 252
Status : Valid
NDC Package Code : 72955-100
Start Marketing Date : 2019-03-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32240
Submission : 2018-08-30
Status : Active
Type : II
NDC Package Code : 55570-520
Start Marketing Date : 2013-12-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26398
Submission : 2012-09-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23634
Submission : 2010-05-06
Status : Inactive
Type : II
NDC Package Code : 60396-1005
Start Marketing Date : 2014-05-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2022-02-03
Valid Till : 2025-02-03
Written Confirmation Number : WC-0518
Address of the Firm :
Certificate Number : R1-CEP 2017-015 - Rev 00
Issue Date : 2023-07-31
Type : Chemical
Substance Number : 252
Status : Valid
NDC Package Code : 80723-100
Start Marketing Date : 2020-10-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Certificate Number : R1-CEP 2012-347 - Rev 01
Issue Date : 2022-04-13
Type : Chemical
Substance Number : 252
Status : Valid
NDC Package Code : 80723-100
Start Marketing Date : 2020-10-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
62
PharmaCompass offers a list of Zinc Oxide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zinc Oxide manufacturer or Zinc Oxide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zinc Oxide manufacturer or Zinc Oxide supplier.
PharmaCompass also assists you with knowing the Zinc Oxide API Price utilized in the formulation of products. Zinc Oxide API Price is not always fixed or binding as the Zinc Oxide Price is obtained through a variety of data sources. The Zinc Oxide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A A&D Medicated Ointment manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of A&D Medicated Ointment, including repackagers and relabelers. The FDA regulates A&D Medicated Ointment manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. A&D Medicated Ointment API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of A&D Medicated Ointment manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A A&D Medicated Ointment supplier is an individual or a company that provides A&D Medicated Ointment active pharmaceutical ingredient (API) or A&D Medicated Ointment finished formulations upon request. The A&D Medicated Ointment suppliers may include A&D Medicated Ointment API manufacturers, exporters, distributors and traders.
click here to find a list of A&D Medicated Ointment suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A A&D Medicated Ointment DMF (Drug Master File) is a document detailing the whole manufacturing process of A&D Medicated Ointment active pharmaceutical ingredient (API) in detail. Different forms of A&D Medicated Ointment DMFs exist exist since differing nations have different regulations, such as A&D Medicated Ointment USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A A&D Medicated Ointment DMF submitted to regulatory agencies in the US is known as a USDMF. A&D Medicated Ointment USDMF includes data on A&D Medicated Ointment's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The A&D Medicated Ointment USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of A&D Medicated Ointment suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The A&D Medicated Ointment Drug Master File in Japan (A&D Medicated Ointment JDMF) empowers A&D Medicated Ointment API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the A&D Medicated Ointment JDMF during the approval evaluation for pharmaceutical products. At the time of A&D Medicated Ointment JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of A&D Medicated Ointment suppliers with JDMF on PharmaCompass.
A A&D Medicated Ointment CEP of the European Pharmacopoeia monograph is often referred to as a A&D Medicated Ointment Certificate of Suitability (COS). The purpose of a A&D Medicated Ointment CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of A&D Medicated Ointment EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of A&D Medicated Ointment to their clients by showing that a A&D Medicated Ointment CEP has been issued for it. The manufacturer submits a A&D Medicated Ointment CEP (COS) as part of the market authorization procedure, and it takes on the role of a A&D Medicated Ointment CEP holder for the record. Additionally, the data presented in the A&D Medicated Ointment CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the A&D Medicated Ointment DMF.
A A&D Medicated Ointment CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. A&D Medicated Ointment CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of A&D Medicated Ointment suppliers with CEP (COS) on PharmaCompass.
A A&D Medicated Ointment written confirmation (A&D Medicated Ointment WC) is an official document issued by a regulatory agency to a A&D Medicated Ointment manufacturer, verifying that the manufacturing facility of a A&D Medicated Ointment active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting A&D Medicated Ointment APIs or A&D Medicated Ointment finished pharmaceutical products to another nation, regulatory agencies frequently require a A&D Medicated Ointment WC (written confirmation) as part of the regulatory process.
click here to find a list of A&D Medicated Ointment suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing A&D Medicated Ointment as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for A&D Medicated Ointment API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture A&D Medicated Ointment as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain A&D Medicated Ointment and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a A&D Medicated Ointment NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of A&D Medicated Ointment suppliers with NDC on PharmaCompass.
A&D Medicated Ointment Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of A&D Medicated Ointment GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right A&D Medicated Ointment GMP manufacturer or A&D Medicated Ointment GMP API supplier for your needs.
A A&D Medicated Ointment CoA (Certificate of Analysis) is a formal document that attests to A&D Medicated Ointment's compliance with A&D Medicated Ointment specifications and serves as a tool for batch-level quality control.
A&D Medicated Ointment CoA mostly includes findings from lab analyses of a specific batch. For each A&D Medicated Ointment CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
A&D Medicated Ointment may be tested according to a variety of international standards, such as European Pharmacopoeia (A&D Medicated Ointment EP), A&D Medicated Ointment JP (Japanese Pharmacopeia) and the US Pharmacopoeia (A&D Medicated Ointment USP).